We found the expression of ABL1 was remarkably elevated in CRC tissues and cell lines (Figure 1), which is corresponded to the survival rate among patients with CRC (Figure S5), indicating ABL1 is a potential oncogene in CRC (13–15). This evidence concerns the gene ABL1 and colorectal carcinoma.